These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7506337)

  • 1. Loop diuretic therapy in liver cirrhosis with ascites.
    Laffi G; La Villa G; Carloni V; Foschi M; Bartoletti L; Quartini M; Gentilini P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 3():S51-8. PubMed ID: 7506337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of ascites in cirrhosis.
    Gerbes AL
    J Hepatol; 1993; 17 Suppl 2():S4-9. PubMed ID: 8491970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of diuretics in the treatment of ascites in patients with cirrhosis].
    Bourgeois N; Devaere S; Adler M; Cremer M
    Acta Gastroenterol Belg; 1990; 53(2):256-60. PubMed ID: 2267905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of loop diuretics: a comparative study.
    Ansuini R; Pulido M; Pupita G; Gaggi S; Pupita F
    Int J Clin Pharmacol Res; 1985; 5(2):113-21. PubMed ID: 4018941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
    Gerbes AL; Bertheau-Reitha U; Falkner C; Jüngst D; Paumgartner G
    J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
    Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
    Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related effects of furosemide, bumetanide, and piretanide on the thick ascending limb function in the rat.
    Gutsche HU; Müller-Ott K; Brunkhorst R; Niedermayer W
    Can J Physiol Pharmacol; 1983 Feb; 61(2):159-65. PubMed ID: 6301665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemide.
    Bernardi M; De Palma R; Trevisani F; Santini C; Patrono D; Motta R; Servadei D; Gasbarrini G
    Hepatology; 1986; 6(3):400-5. PubMed ID: 3519416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
    Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
    Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of ascites associated with cirrhosis.
    Ginès P; Arrovo V; Rodés J
    Drugs; 1992 Mar; 43(3):316-32. PubMed ID: 1374317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiloride ('MK 870') in patients with ascites due to cirrhosis of the liver.
    Senewiratne B; Sherlock S
    Lancet; 1968 Jan; 1(7534):120-2. PubMed ID: 4169604
    [No Abstract]   [Full Text] [Related]  

  • 16. Diuretic use in critical care.
    Narins RG; Chusid P
    Am J Cardiol; 1986 Jan; 57(2):26A-32A. PubMed ID: 3511655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites.
    Abecasis R; Guevara M; Miguez C; Cobas S; Terg R
    Scand J Gastroenterol; 2001 Mar; 36(3):309-13. PubMed ID: 11305520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients].
    Marelli A; Bodini P; Reggiani A; Quinzani M; Dizioli P; Tonghini L
    Minerva Med; 1997 Mar; 88(3):109-15. PubMed ID: 9148226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.